Biotech grants in the United Kingdom

Between cycles

Funds UK founders starting or growing a young business with a government-backed personal loan and 12 months of mentoring.

Between cycles

Supports women founders with a focused programme of mentorship and investor readiness for startup growth.

Between cycles

Supports scaling Scottish technology businesses with hybrid grant-loan funding and growth recognition.

Closed

Turn a public sector research asset into something a market will pay for.

Closed

Supports early-stage founders from Commonwealth countries with mentoring, masterclasses, and investor-facing acceleration.

Closed

Funding for entrepreneurship-focused doctoral training and venture creation.

Closed

Pays up to £5,000 to teams solving real-world problems with probabilistic computing.

Closed

Pays UK university ventures, startups and SMEs a share of £150,000 in equity-free cash prizes through a national pitching competition.

Closed

Awards UK tech innovators cash prizes after free workshops and live pitching.

Closed

Flexible early-stage funding for research organisations to progress research impact.

Closed

Awards UK-incorporated innovators up to £650,000 in total -- up to £100,000 as a Finalist, then up to £550,000 more as a Winner -- to develop and scale an innovation for the water sector in England and Wales.

Closed

Funds early-stage water-sector innovations with staged seed funding for finalists and winners.

Closed

Offers non-dilutive financing for United Kingdom firms to scale late-stage innovation when standard debt is unavailable.

Closed

Funds Northern Ireland businesses accessing knowledge-provider expertise through GBP 5K innovation vouchers.

Open

Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.

Open

Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.

Open

Pays an equity-free cash prize to the top healthcare startup pitching live at WHX Tech's Xcelerate competition in Dubai.

Open

Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.

Open

Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.

Open

Funds new analysis of clinical, genomic, environmental and registry data that already exists, to sharpen who is at risk of cancer and what happens to them.

Open

Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.

Open

Funds proof-of-concept work on a genuinely new tool, assay, platform or instrument for characterising cancer cells or handling biospecimens.

Open

Funds the same reanalysis of already-collected cancer data on a smaller, exploratory footing, for teams that do not need a full research project award.

Open

Funds exploratory studies of the ethical, legal and social consequences of human genetics, especially where a technology or a use of genomic data is new.